CorMedix Inc. (NASDAQ:CRMD) Q4 2024 Earnings Call Transcript March 25, 2025
CorMedix Inc. beats earnings expectations. Reported EPS is $0.22, expectations were $0.17.
Operator: Good day and welcome to the CorMedix Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note today’s event is being...
